Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Spyre Therapeutics, Inc.

NASDAQ: SYRE · Life Sciences · 6 alerts · CIK 1636282

Share price
$99.37Close, Nov 16
Market cap
$9.44B
Shares outstanding
94.97MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Spyre Therapeutics, Inc. filings on SEC EDGAR ↗

9:30 PM ET Form 4
Insider Selling

Spyre Therapeutics Insider Heidy King-Jones Sells $2.63M of Stock

Heidy King-Jones sold 28,933 shares of Spyre Therapeutics, Inc. at $89.24 to $93.46 a share (average $91.03) in 5 transactions, worth $2.63M in total on Oct 1, 2026. Shares held after the trade: 2,845 (-47.8%).

Value
$2.63M
Shares
28,933
Average price
$91.03
Holding change
-47.8%
Trade date
Oct 1, 2026
9:30 PM ET Form 4
Insider Selling

Spyre Therapeutics CEO Cameron Turtle Sells $1.37M of Stock

Cameron Turtle, CEO, sold 14,900 shares of Spyre Therapeutics, Inc. at $89.14 to $93.37 a share (average $91.99) in 5 transactions, worth $1.37M in total on Oct 1, 2026. Shares held after the trade: 537,640 (-0.9%).

Value
$1.37M
Shares
14,900
Average price
$91.99
Role
CEO
Holding change
-0.9%
Trade date
Oct 1, 2026
9:29 PM ET Form 4
Insider Selling

Spyre Therapeutics CFO Scott L. Burrows Sells $2.26M of Stock

Scott L. Burrows, CFO, sold 25,000 shares of Spyre Therapeutics, Inc. at $89.07 to $93.57 a share (average $90.47) in 6 transactions, worth $2.26M in total between Sep 30, 2026 and Oct 1, 2026. Shares held after the trade: 79,762 (-0.3%).

Value
$2.26M
Shares
25,000
Average price
$90.47
Role
CFO
Holding change
-0.3%
Trade date
Sep 30, 2026 to Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.